Dermatologists' Perspectives on Biosimilars
Conclusion: Biosimilars are safe and effective for treating approved dermatological conditions and may lower patient costs compared to their reference products. Patients are not always offered biosimilar therapy as an option, which may be due to unfamiliarity among dermatologists. This survey suggests a need for more research and educational initiatives, such as modules and workshops that focus on biosimilar safety, efficacy, and interchangeability guidelines. J Drugs Dermatol. 2024;23(4):doi:10.36849/JDD.7755.PMID:38564397 | DOI:10.36849/JDD.7755
Source: Journal of Drugs in Dermatology - Category: Dermatology Authors: Priscila Arellano Zameza Christina Kontzias Keith Flanders Peter Sonnenreich Steven R Feldman Source Type: research
More News: Dermatology | Education | Hidradenitis | Legislation | Psoriasis | Skin | Study | Workshops